PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Bruker Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruker Introduces the Molecular Drug Imager™ Solution for Small Molecule Drug Discovery and Development - Powerful Dual Mass Spectrometry Imaging Workflows for MALDI-based Molecular Imaging Yield Spatial Drug and Metabolite Distributions in Tissue, and Assist Biomarker Discovery and Validation - Bruker.com
Bruker Introduces the Molecular Drug Imager™ Solution for Small Molecule Drug Discovery and Development

 

NewswireToday - /newswire/ - Orlando, FL, United States, 2015/10/21 - Powerful Dual Mass Spectrometry Imaging Workflows for MALDI-based Molecular Imaging Yield Spatial Drug and Metabolite Distributions in Tissue, and Assist Biomarker Discovery and Validation - Bruker.com. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Electronics/Instrumentation/RFID Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

At the 10th International Society for the Study of Xenobiotics (ISSX) meeting, Bruker today announced the novel Molecular Drug Imager™ solution for pre-clinical drug and metabolite imaging.

MALDI-based tissue imaging for pharmaceutical development has provided researchers with a powerful technique for localizing small molecule drugs and their metabolites, or lipids, within tissue structures, providing key insights into physiological function that were unavailable with previous technologies. With its powerful software and workflow flexibility, the new Molecular Drug Imager solution is poised to take small molecule mass spectrometry imaging (MSI) to the next level by empowering fast, accurate, and thorough evaluation of drug candidates and their metabolites in model tissues and beyond.

For more than a decade, Bruker has provided industry-leading advances in hardware and methods for MALDI-based mass spectrometry imaging. The recently introduced rapifleX™ MALDI-TOF system has set new standards for speed and pixel fidelity for protein imaging and molecular histology research, while the solariX XR™ FTMS system successfully merged MALDI small molecule imaging with Isotopic Fine Structure (IFS) analysis for undisputable molecular formula specificity.

The Molecular Drug Imager leverages the unparalleled power of solariX-based small molecule imaging to provide a comprehensive analysis-to-answer imaging workflow solution to enable pharmaceutical investigators at all levels, from biomarker discovery and validation to drug development studies. Many of the top-25 pharma companies are already using earlier versions of this MSI technology in their pre-clinical efforts to complement or replace expensive workflows, such as Quantitative Whole-Body Autoradiography (QWBA), and to migrate certain animal based pre-clinical models to tissue proxies.

About the Molecular Drug Imager
Providing traditional MALDI imaging analysis functions such as combining optical and molecular images, the Molecular Drug Imager in its first workflow facilitates localizing multi-generational ­metabolic products of drug candidates by in silico metabolism followed by automated image generation of predicted metabolites in analyzed tissues. This results in a significant time savings through automation of this critical workflow, which is becoming commonplace in advanced laboratories worldwide.

The second advanced workflow provides a rapid discovery tool based on comprehensive statistical treatment of imaging datasets. Powered by the SCiLS lab software suite, powerful next-generation statistical algorithms such as PLSA and univariate and multivariate modalities can rapidly analyze imaging regions to identify unknown metabolites and biomarkers through spatial co-localization.

The Molecular Drug Imager solution is also being featured simultaneously at the Society for Toxicological Pathology Meeting in Minneapolis, Minnesota on October 17-21.

About Bruker Corporation
For more than 50 years, Bruker (bruker.com) has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, Nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics.

Investor Contact: Joshua Young - Vice President, Investor Relations - Bruker Corporation
T: +1 978-667-9580 x1479 E: joshua.young[.]bruker.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Electronics/Instrumentation/RFID Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Electronics/Instrumentation/RFID articles,
CATCH Visitors via Your Competitors Announcements!


Bruker Introduces the Molecular Drug Imager™ Solution for Small Molecule Drug Discovery and Development

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Bruker Corporation | Molecular Drug Imager
Publisher Contact: Mike Easterling - Bruker Daltonics 
978-873-0949 michael.easterling[.]bruker.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Electronics/Instrumentation/RFID via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bruker Corporation / Company Profile


Read Electronics/Instrumentation/RFID Most Recent Related Newswires:

NI Unveils the Next Generation of LabVIEW
Bruker Launches the S8 TIGER™ Series 2 WDXRF System for Elemental Analysis in Industrial and Academic Research and Materials Quality Control
GE Expands Board-Level Power Conversion Capabilities with Next-Generation DLynx* II Digital, Non-Isolated DC-DC Voltage Converters
LED Lighting Industry - Middle East to Become One of the Fastest Growing Markets Finds Frost & Sullivan
Hitachi High Tech Science Park to Open in California
Frost & Sullivan Acclaims Kamstrup for its Highly Customer-centric Smart Water Meter Solutions
Curtiss-Wright’s New QorIQ® T2080-based COTS Single Board Computer Speeds and Lowers the Cost of DO-254 DAL A Safety Certifiability
Bruker Acquires Emerging Light Sheet Microscopy Company Luxendo
Curtiss-Wright Expands Industry-Leading Counterfeit Mitigation Efforts with Improved Obsolescence Mitigation Reporting Procedures
NI Announces New Multichannel Mixed-Signal Instruments to Lower Cost and Size of Automated Test Systems
Enel Energia, Nissan Italia and IIT Join Forces for the Development of Electric Mobility
ESA Satellite with Noliac Piezo Actuator Stacks in Space
Curtiss-Wright Selected by Bell Helicopter Canada to Provide Cockpit Voice/Flight Data Recorder System
Toyota Acknowledges Infineon for Outstanding Quality
Curtiss-Wright, Lynx Software Technologies, ENSCO Avionics, and CoreAVI Demo LynxOS®-178 Safety Certified RTOS for Single Board Computers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)